Pular para o conteúdo
Merck
  • Cadherin-11 coordinates cellular migration and extracellular matrix remodeling during aortic valve maturation.

Cadherin-11 coordinates cellular migration and extracellular matrix remodeling during aortic valve maturation.

Developmental biology (2015-07-19)
Caitlin J Bowen, Jingjing Zhou, Derek C Sung, Jonathan T Butcher
RESUMO

Proper remodeling of the endocardial cushions into thin fibrous valves is essential for gestational progression and long-term function. This process involves dynamic interactions between resident cells and their local environment, much of which is not understood. In this study, we show that deficiency of the cell-cell adhesion protein cadherin-11 (Cad-11) results in significant embryonic and perinatal lethality primarily due to valve related cardiac dysfunction. While endocardial to mesenchymal transformation is not abrogated, mesenchymal cells do not homogeneously cellularize the cushions. These cushions remain thickened with disorganized ECM, resulting in pronounced aortic valve insufficiency. Mice that survive to adulthood maintain thickened and stenotic semilunar valves, but interestingly do not develop calcification. Cad-11 (-/-) aortic valve leaflets contained reduced Sox9 activity, β1 integrin expression, and RhoA-GTP activity, suggesting that remodeling defects are due to improper migration and/or cellular contraction. Cad-11 deletion or siRNA knockdown reduced migration, eliminated collective migration, and impaired 3D matrix compaction by aortic valve interstitial cells (VIC). Cad-11 depleted cells in culture contained few filopodia, stress fibers, or contact inhibited locomotion. Transfection of Cad-11 depleted cells with constitutively active RhoA restored cell phenotypes. Together, these results identify cadherin-11 mediated adhesive signaling for proper remodeling of the embryonic semilunar valves.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
MISSION® esiRNA, targeting human GCNT2
Sigma-Aldrich
MISSION® esiRNA, targeting human VIPR1
Sigma-Aldrich
MISSION® esiRNA, targeting human CD74
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Tcn2
Sigma-Aldrich
MISSION® esiRNA, targeting human TAF8
Sigma-Aldrich
MISSION® esiRNA, targeting human ST6GALNAC2
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Cd74
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Vipr1
Sigma-Aldrich
MISSION® esiRNA, targeting human TCN2
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Taf8